News Archive - Page 23 of 25

Global collaboration to produce vaccine to help prevent epilepsy in the developing world

2012-03-22

The first industrially produced vaccine against porcine cysticercosis is eagerly anticipated as a result of a new partnership between GALVmed, Indian Immunologicals Limited (IIL) and the University of Melbourne. The tapeworm Taenia solium is a human parasite with the intermediate host being the pig. Globally, the parasite is estimated to cause 50 million human cases of taeniasis […]

Interim CEO

2012-03-22

Interim CEO Steve Sloan’s last official function as GALVmed CEO was on 1 December 2011 when he attended the commissioning event for the equipment and facilities provided to the National Veterinary Institute, Ethiopia under the VACNADA programme. The process for recruiting Steve’s successor is currently underway. Meanwhile an Interim CEO has been appointed – Professor […]

Interview with Dr Johan Vanhemelrijck at the GALVmed WHO Conference

2012-03-22

Images from our ND vaccine pilot projects in India

2012-03-22

Images from Newcastle Disease vaccine pilot projects in Odisha, India where GALVmed is working with implementing partners BMPCS & PRADAN.

Fact-finding visits to Africa

2012-03-22

Steve Sloan, GALVmed’s Chief Executive, completed fact-finding visits to Uganda, Kenya and Tanzania in October 2007 to discuss infect and treatment methodologies for East Coast fever (ECF). Mr Sloan was accompanied by Professor Andy Peters, Arpexas consultant expert on vaccination production, Dr Hamed Nuru, Director of Partnerships for African Union/Interafrican Bureau for Animal Resources (AU/IBAR) […]

East Coast Fever Vaccine Launch, Arusha Tanzania

2012-03-22

The East Coast fever Infection and Treatment Method vaccine (ECF-ITM) launch was organised by AU-IBAR, PANVAC, the Government of Tanzania, Dr Lieve Lynen and GALVmed as a platform to bring together key stakeholders in the manufacture, delivery and adoption of the ECF-ITM vaccine for the purpose of officially launching the vaccine in Tanzania. This was […]

Facilitating the registration and commercialisation of ECF vaccine

2012-03-22

As part of its strategy to promote affordable vaccines and pharmaceutical products to poor livestock keepers, GALVmed is to be part of a task force led by AU/IBAR to facilitate the registration and commercialisation of the Muguga Cocktail (MC) vaccine for East Coast fever. In partnership with representatives from AU/IBAR, PANVAC, Kenya, Uganda, Tanzania and […]

UNDP-EMRC AgriBusiness Forum

2012-03-22

This year, the UNDP-EMRC AgriBusiness Forum will focus on “Engaging the Private Sector for Africa’s Agri-Food Growth”, following the recent international policies focusing on ensuring inclusive agricultural strategies. The success of Africa depends on the success of its private sector, and EMRC encourages the international community of entrepreneurs, donors, financiers, civil society and officials to become fully involved […]

Street Theatre in Orissa Creating Vaccine Awareness

2012-03-22

Traditional street theatre is being staged in Orissa, India to share key messages about the relevance to local communities of Newcastle Disease (known locally as Marudi), Peste de Petits Ruminants (PPR) and interventions available to tackle these diseases. PRADAN, the experienced implementing partner for GALVmed’s Newcastle Disease pilot project recognises street theatre as a culturally […]

Tryps Experts Combine Expertise

2012-03-22

Back Row, from left to right: Tim Rowan (GALVmed Consultant), Philippe Buscher (Department of Parasitology, Institute of Tropical Medicine Antwerp, Antwerpen), Stefan Magez (Vrije Universiteit Brussel), Mike Witty (GALVmed Chair), Alasdair Swift (UK’s Department for International Develpoment [DFID]), Christine Clayton (Univ Heidelberg,Germany). Front Row, from left to right: Francis Oloo (Consultant), Baptiste Dungu (GALVmed), Robert Don (Discovery & […]